Skip to main content
. 2015 Sep 28;15(4):329–333. doi: 10.1007/s40268-015-0108-6

Table 3.

Stability of water preparation of tedizolid phosphate and levels of degradation products/impurities after incubation

Time (h) Recovery of 200-mg dose commercial tablet (%) Tedizolid (% area by HPLC) Unspecified RRT 1.37 (% area by HPLC)
0 93.9 <0.05 0.05
4 94.7 0.05 0.06

HPLC high-performance liquid chromatography, RRT relative retention time